Safety and Efficacy of Weekly Paclitaxel and Cisplatin Chemotherapy for Ovarian Cancer Patients with Hypersensitivity to Carboplatin

Safety and Efficacy of Weekly Paclitaxel and Cisplatin Chemotherapy for Ovarian Cancer Patients with Hypersensitivity to Carboplatin

Background: This study aimed to evaluate the safety and efficacy of weekly paclitaxel and cisplatin chemotherapy (wTP) in patients with ovarian cancer who developed carboplatin hypersensitivity reaction (HSR). Methods: We retrospectively investigated 86 patients with ovarian, fallopian tube, and per...

Full description

Bibliographic Details
Main Authors: Shinichi Tate, Kyoko Nishikimi, Ayumu Matsuoka, Satoyo Otsuka, Makio Shozu
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cancers
Subjects:
carboplatin
cisplatin
hypersensitivity reaction
ovarian cancer
platinum-sensitive disease
recurrence
Online Access:https://www.mdpi.com/2072-6694/13/4/640

Internet

https://www.mdpi.com/2072-6694/13/4/640

Similar Items